Abstract
We administered sodium dichloroacetate (DCA), which reduces the circulating lactate and pyruvate concentrations by stimulating the activity of the pyruvate dehydrogenase complex (PDHC), to three children with mitochondrial encephalomyelopathy. Significant clinical, biochemical and radiologic improvements were obtained following DCA therapy (approximately 30 mg/kg per day, divided into three doses). All three patients had non-pyruvate dehydrogenase complex (PDHC) deficiencies: two exhibited Leigh syndrome (complex I deficiency and unknown etiology), and one abnormal myelination (multienzyme deficiency), demonstrated on magnetic resonance imaging (MRI). The lactic and pyruvic acid concentrations in serum and cerebrospinal fluid (CSF) were decreased significantly by the oral DCA treatment. The lactic acid peak on MR spectroscopy also markedly decreased in parallel with the CSF level. In addition, the brain lesions observed on MRI were improved in all patients. No exacerbation was observed in any of the patients, who have been followed-up more than 21 months following the DCA therapy. These results suggest that DCA therapy should be considered in all patients with a mitochondria-related enzyme deficiency.
References
May 4, 1976·European Journal of Pediatrics·H MaesakaK Tada
Nov 1, 1992·Neurology·A M PennN G Kennaway
Nov 1, 1992·Brain & Development·M BurgeoisJ Aicardi
Jan 1, 1992·Pediatric Neurology·I Krägeloh-MannW Ruitenbeek
Jun 1, 1992·Neuropediatrics·F A WijburgR B Schutgens
Jul 1, 1991·Journal of the Neurological Sciences·R Van CosterJ F Schwartz
Aug 1, 1991·Neuropediatrics·T SaijoY Kuroda
Jan 1, 1990·The Journal of Pediatrics·T FujiiH Mikawa
Oct 1, 1987·Annals of Neurology·S DiMauroS D Johnsen
Jan 1, 1986·Journal of Inherited Metabolic Disease·Y KurodaK Yamashita
Oct 1, 1985·American Journal of Medical Genetics·K McCormickJ Heininger
Aug 18, 1983·The New England Journal of Medicine·P W StacpooleR I Misbin
Jun 1, 1982·Pediatric Research·K ToshimaK Ii
Mar 1, 1995·Brain & Development·D I ZafeiriouM Jensen
Jun 1, 1995·Neurology·N De StefanoD L Arnold
Sep 1, 1993·The Journal of Pediatrics·P P TóthJ M Klein
Dec 1, 1995·Journal of the Neurological Sciences·S KimuraA Nezu
Citations
Feb 27, 2004·Current Neurology and Neuroscience Reports·Andrea Gropman
Apr 3, 2001·Current Treatment Options in Neurology·Roser Pons, Darryl C. De Vivo
Aug 6, 2002·Pediatric Neurology·Tatsuya FujiiTakehiko Okuno
Mar 18, 2006·Neuroimaging Clinics of North America·Kim M Cecil
Sep 8, 2010·Developmental Disabilities Research Reviews·Seth D FriedmanRussell P Saneto
Mar 12, 2010·Journal of Applied Toxicology : JAT·Ezdihar A HassounJessica Spildener
Oct 7, 2004·Molecular Genetics and Metabolism·Bruce A BarshopRichard H Haas
Jul 2, 2008·Mitochondrion·Russell P SanetoDennis W W Shaw
Feb 15, 2008·Journal of Biochemical and Molecular Toxicology·Ezdihar A Hassoun, Soumyadeep Dey
May 22, 2008·Journal of Applied Toxicology : JAT·Ezdihar A Hassoun, Jatin Mehta
Apr 22, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Yoshiki KatsumiTohru Sugimoto
Jul 8, 2000·Brain Pathology·G Manfredi, M F Beal
Dec 7, 2011·Developmental Medicine and Child Neurology·Gaia GiribaldiClaudio Bruno
Mar 31, 2015·Ukrainskiĭ biokhimicheskiĭ zhurnal·S V KhyzhnyakA A Kaplia